In a sign of weak demand, medical device maker Thermage was forced to price its 6 million share offering at $7, a 42% discount to its originally proposed range. The Hayward, CA based company has developed a noninvasive monopolar radio frequency systems to tighten skin on any part of the body. Merrill Lynch lead managed the IPO, and the stock is set to begin trading on the NASDAQ under the ticker symbol "THRM" on Friday.
